BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 1679757)

  • 1. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE
    Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 3. The purine analogs--a therapeutic beauty contest.
    Cheson BD
    J Clin Oncol; 1992 May; 10(5):868-71. PubMed ID: 1349035
    [No Abstract]   [Full Text] [Related]  

  • 4. The purine analogs--a therapeutic beauty contest.
    Cheson BD
    J Clin Oncol; 1992 Mar; 10(3):352-5. PubMed ID: 1346799
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Juliusson G; Elmhorn-Rosenborg A; Liliemark J
    N Engl J Med; 1992 Oct; 327(15):1056-61. PubMed ID: 1355853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on purine analogues.
    Cheson BD
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse and beneficial immunological effects of purine nucleoside analogues.
    Dighiero G
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S75-81. PubMed ID: 9137960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentostatin in chronic lymphocytic leukemia.
    Sauter C; Lamanna N; Weiss MA
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1217-22. PubMed ID: 18721115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis induction with purine analogs on freshly isolated chronic myeloid leukemia cells.
    Zinzani PL; Martinelli G; Buzzi M; Farabegoli P; Bendandi M; Tura S
    Haematologica; 1995; 80(4):390-1. PubMed ID: 7590510
    [No Abstract]   [Full Text] [Related]  

  • 10. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.
    Saven A; Piro LD
    Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
    Spiers AS
    Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of chronic lymphatic leukemia].
    Adam Z; Vorlícek J; Hejlová N
    Vnitr Lek; 1996 Aug; 42(8):573-8. PubMed ID: 8967031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of purine nucleoside analogues.
    Plunkett W; Gandhi V
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S67-74. PubMed ID: 9137959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
    Saven A
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):31-3. PubMed ID: 7908757
    [No Abstract]   [Full Text] [Related]  

  • 15. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
    Fabianowska-Majewska K; Wyczechowska D
    Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine analogs in the treatment of chronic lymphocytic leukemia.
    Pott C; Hiddemann W
    Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairy cell leukemia. What is new forty years after the first description?
    Troussard X; Maloisel F; Flandrin G
    Hematol Cell Ther; 1998 Aug; 40(4):139-48. PubMed ID: 9766918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present status of purine analogs in the therapy of chronic lymphocytic leukemias.
    Bergmann L
    Leukemia; 1997 Apr; 11 Suppl 2():S29-34. PubMed ID: 9178835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
    Nabhan C; Gartenhaus RB; Tallman MS
    Leuk Res; 2004 May; 28(5):429-42. PubMed ID: 15068894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.